| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |